Osteoclast inhibition for the treatment of bone metastases.
Coleman
R E
RE
YCRC Department of Clinical Oncology, Weston Park Hospital, Sheffield, U.K.
Purohit
O P
OP
D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy; D001862:Bone Resorption / Q000209:etiology / Q000517:prevention & control*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology / Q000517:prevention & control; D010010:Osteoclasts / Q000187:drug effects*
D004164:Diphosphonates